venture capital Archives -

The new pharma collaborations driving transformative research in oncology

News/ News/ News/ Oncology/ R&D

Cancer Research UK partnership aims to back 10 new startups

Phil Taylor Cancer Research UK, Deep Science Ventures, financing, Oncology, startup, venture capital 0 Comment

Cancer Research UK has expanded an alliance with investment group Deep Science Ventures with a commitment to support

Cancer Research UK partnership aims to back 10 new startups

https://pharmaphorum.com/news/cancer-research-uk-partnership-aims-to-back-10-new-startups/

The rise and rise of digital health investment

News/ News/ R&D

UK biotech investment at record levels amid COVID-19

Phil Taylor financing, investment, IPO, UK, UK biotech, venture capital 0 Comment

New figures have confirmed that the UK’s biotech sector received a massive boost from the COVID-19 pandemic last

UK biotech investment at record levels amid COVID-19

https://pharmaphorum.com/news/uk-biotech-investment-at-record-levels-amid-covid-19/

News/ News/ R&D

VC fund dedicated to psychedelic meds launches in UK

Phil Taylor addiction, anxiety, depression, financing, ketamine, mushrooms, Neo Kuma Ventures, psychedelics, UK, venture capital 0 Comment

In the last few years, biopharma companies focusing on psychedelic medicines have been springing up like mushrooms –

VC fund dedicated to psychedelic meds launches in UK

https://pharmaphorum.com/news/vc-fund-dedicated-to-psychedelic-meds-launches-in-uk/

Digital-health-literacy--the-bright-tail-of-the-comet

Digital/ News/ News

Olive Tree Ventures closes $170m dedicated digital health fund

Richard Staines digital health, investment, Olive Tree Ventures, venture capital 0 Comment

Israel’s specialist venture capital firm, Olive Tree Ventures (OTV) has closed a fund worth $170 million, with plans

Olive Tree Ventures closes $170m dedicated digital health fund

https://pharmaphorum.com/news/olive-tree-ventures-closes-170m-dedicated-digital-health/

News/ News/ R&D

VC firm SR One completes GSK spin-out, raising $500m

Richard Staines Biotech, GlaxoSmithKline, SR One, venture capital 0 Comment

Trans-Atlantic biotech venture capital firm SR One has completed its spin-out from GlaxoSmithKline and closed its first fund

VC firm SR One completes GSK spin-out, raising $500m

https://pharmaphorum.com/news/vc-sr-one-completes-gsk-spin-out-raising-500m/

News/ News/ R&D

Kyowa Kirin backs €125m life science fund closed by Fountain Healthcare

Phil Taylor European biotech, financing, Fountain Healthcare, Kyowa Kirin, Life Sciences, venture capital 0 Comment

Ireland-based Fountain Healthcare Partners has raised another €125 million ($131 million) for its third life sciences fund –

Kyowa Kirin backs €125m life science fund closed by Fountain Healthcare

https://pharmaphorum.com/news/kyowa-kirin-backs-e125m-life-science-fund-closed-by-fountain-healthcare/

Sales and Marketing/ Views & Analysis/ Views and analysis

Agents for change: the women breaking through in life sciences venture capital

Richard Staines investment, venture capital, women in science 0 Comment

For a long time, venture capital (VC) firms have been controlled mainly by men. But things are changing

Agents for change: the women breaking through in life sciences venture capital

https://pharmaphorum.com/views-analysis-sales-marketing/agents-for-change-the-women-breaking-through-in-life-sciences-venture-capital/

Digital/ News/ News/ News/ News/ R&D/ Startups/ Top stories

European VCs ‘actively seeking new healthcare investments’

Phil Taylor Europe, investment, Life Sciences, venture capital 0 Comment

The disruption caused by the coronavirus crisis hasn’t dampened the enthusiasm of European venture capitalists to make funding

European VCs ‘actively seeking new healthcare investments’

https://pharmaphorum.com/news/european-vcs-actively-seeking-new-healthcare-investments/

News/ News/ R&D

BMS backs record $600m European venture fund closed by LSP

Phil Taylor European biotech, investment, Life Sciences, venture capital 0 Comment

Venture capital group Life Science Partners has closed its sixth investment round, raising a record $600 million that

BMS backs record $600m European venture fund closed by LSP

https://pharmaphorum.com/news/bms-backs-record-600m-european-venture-fund-closed-by-lsp/

Trending

venture capital

Login